Institutional investors purchased a net $3.7 million shares of OPK during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 18.50% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LBMC INVESTMENT ADVISORS LLC Bought 1.6 Million shares of OPKO Health Inc
STONERIDGE INVESTMENT PARTNERS L... Bought 350.9 Thousand shares of OPKO Health Inc
EXCELLENCE NESSUAH MUTUAL FUNDS ... Bought 74.2 Thousand shares of OPKO Health Inc